Key results
Result highlights
The story
A global pharmaceutical leader and maker of Ozempic develops medicines for chronic diseases, facing strict regulatory requirements that demand massive volumes of documentation for every new treatment.
Producing a single clinical study report was a multi-month cycle, with staff writers averaging only 2.3 reports per year while daily delays cost up...
Quotes
“Claude has helped us cut writing times on CSRs by 90% so we can get documentation directly into human hands for review and approval.”
The company
Novo Nordisk
novonordisk.comPharmaceutical company specializing in diabetes, obesity, and rare blood disorders.
Scope & timeline
- Prototyping time cut from weeks to hours